M&T Bank Corp Instil Bio, Inc. Transaction History

M&T Bank Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $48,499 - $76,869	-10,430 Reduced 10.31%	90,740 $440,000
Q2 2022 Aug 05, 2022	BUY	$4.21 - $11.15 $359,382 - $951,808	85,364 Added 540.07%	101,170 $468,000
Q1 2022 May 09, 2022	BUY	$8.48 - $18.1 $11,134 - $23,765	1,313 Added 9.06%	15,806 $170,000
Q4 2021 Feb 07, 2022	BUY	$15.37 - $22.5 $12,157 - $17,797	791 Added 5.77%	14,493 $248,000
Q3 2021 Oct 28, 2021	BUY	$15.05 - $23.28 $206,215 - $318,982	13,702 New	13,702 $245,000
Q2 2021 Aug 13, 2021	SELL	$15.31 - $24.63 $123,061 - $197,975	-8,038 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$24.23 - $27.06 $194,760 - $217,508	8,038 New	8,038 $202,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.